USP Drug Classification

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level 

 Analgesics
 Anesthetics
 Anti-Addiction/Substance Abuse Treatment Agents
 Antibacterials
 Anticonvulsants
 Antidementia Agents
 Antidepressants
 Antiemetics
 Antifungals
 Antigout Agents
 Antimigraine Agents
 Antimyasthenic Agents
 Antimycobacterials
 Antineoplastics
   Alkylating Agents
     Bendamustine [DG:DG00678]
     Chlorambucil
     Ifosfamide
     Mechlorethamine [DG:DG00677]
     Melphalan [DG:DG00676]
     Carmustine
     Lomustine
     Streptozocin
     Busulfan
     Carboplatin
     Cisplatin
     Cyclophosphamide [DG:DG00675]
       D00287  Cyclophosphamide (USP)
     Dacarbazine [DG:DG00680]
     Lurbinectedin
     Oxaliplatin
     Procarbazine [DG:DG00706]
     Temozolomide
     Thiotepa
     Trabectedin
   Antiandrogens
   Antiestrogens/Modifiers
   Antimetabolites
   Aromatase Inhibitors
   Immunomodulatory Agents
   Molecular Target Inhibitors
   Monoclonal Antibody/Antibody-Drug Conjugate
   Retinoids
   Antineoplastic Adjuncts/Mitigators
   Antineoplastics, Other
 Anti-Obesity Agents
 Antiparasitics
 Antiparkinson Agents
 Antipsychotics
 Antispasticity Agents
 Antivirals
 Anxiolytics
 Bipolar Agents
 Blood Glucose Regulators
 Blood Products and Modifiers
 Cardiovascular Agents
 Central Nervous System Agents
 Contraceptives
 Dental and Oral Agents
 Dermatological Agents
 Electrolytes/Minerals/Metals/Vitamins
 Gastrointestinal Agents
 Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
 Genitourinary Agents
 Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
 Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
 Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins)
 Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
 Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)
 Hormonal Agents, Suppressant (Pituitary)
 Hormonal Agents, Suppressant (Thyroid)
 Immunological Agents
 Infertility Agents
 Inflammatory Bowel Disease Agents
 Metabolic Bone Disease Agents
 Ophthalmic Agents
 Otic Agents
 Respiratory Tract/Pulmonary Agents
 Sexual Disorder Agents
 Skeletal Muscle Relaxants
 Sleep Disorder Agents

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: April 10, 2024
According to the USP Drug Classification 2024

» Japanese version